Stephanie Buart

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

The transmembrane IL-15 isoform expressed on human melanoma cells triggers modulatory effects on tumor progression upon stimulation with the soluble IL-15Rα chain.

The transmembrane IL-15 isoform expressed on human melanoma cells triggers modulatory effects on tumor progression upon stimulation with the soluble IL-15Rα chain.

Journal: Frontiers in immunology
Published: January 28, 2026

Sunitinib Treatment of VHL C162F Cells Slows Down Proliferation and Healing Ability via Downregulation of ZHX2 and Confers a Mesenchymal Phenotype.

Sunitinib Treatment of VHL C162F Cells Slows Down Proliferation and Healing Ability via Downregulation of ZHX2 and Confers a Mesenchymal Phenotype.

Journal: Cancers
Published: October 10, 2023

Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.

Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.

Journal: Seminars in cancer biology
Published: July 31, 2023

The roles of different forms of IL-15 in human melanoma progression.

The roles of different forms of IL-15 in human melanoma progression.

Journal: Frontiers in immunology
Published: March 10, 2023

Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity.

Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity.

Journal: Oncoimmunology
Published: August 09, 2021

The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation.

The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation.

Journal: Cancers
Published: July 02, 2021

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2021

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment.

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment.

Journal: Frontiers in immunology
Published: March 14, 2021

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.

Journal: Frontiers in immunology
Published: October 01, 2020

Hypoxia-driven intratumor heterogeneity and immune evasion.

Hypoxia-driven intratumor heterogeneity and immune evasion.

Journal: Cancer letters
Published: April 27, 2020

Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy.

Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy.

Journal: Seminars in cancer biology
Published: October 14, 2019

AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity.

AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity.

Journal: Cancer immunology research
Published: January 02, 2019
Showing 1-12 of 20

Last Updated: 09/26/2026